195 related articles for article (PubMed ID: 11735743)
1. Cardiovascular events and COX-2 inhibitors.
Konstam MA; Demopoulos LA
JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735743
[No Abstract] [Full Text] [Related]
2. Cardiovascular events and COX-2 inhibitors.
White WB; Whelton A
JAMA; 2001 Dec; 286(22):2811-2. PubMed ID: 11735749
[No Abstract] [Full Text] [Related]
3. Cardiovascular events and COX-2 inhibitors.
Grant KD
JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735744
[No Abstract] [Full Text] [Related]
4. Cardiovascular events and COX-2 inhibitors.
Haldey EJ; Pappagallo M
JAMA; 2001 Dec; 286(22):2809-10; author reply 2811-2. PubMed ID: 11735745
[No Abstract] [Full Text] [Related]
5. Cardiovascular events and COX-2 inhibitors.
Singh G
JAMA; 2001 Dec; 286(22):2810-1; author reply 2811-2. PubMed ID: 11735748
[No Abstract] [Full Text] [Related]
6. Cardiovascular events and COX-2 inhibitors.
Minic M
JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735746
[No Abstract] [Full Text] [Related]
7. Cardiovascular events and COX-2 inhibitors.
Burnakis TG
JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735741
[No Abstract] [Full Text] [Related]
8. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
[No Abstract] [Full Text] [Related]
9. Cardiovascular events and COX-2 inhibitors.
Fleming M
JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
[No Abstract] [Full Text] [Related]
10. [Questions to Professor Jean-François Bretagne].
Bretagne JF
Gastroenterol Clin Biol; 2003 May; 27(5):518-21. PubMed ID: 12843914
[No Abstract] [Full Text] [Related]
11. [Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity].
Ruilope LM; Coca A
Med Clin (Barc); 2002 Feb; 118(6):219-21. PubMed ID: 11864545
[No Abstract] [Full Text] [Related]
12. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
Baigent C; Patrono C
Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
[No Abstract] [Full Text] [Related]
13. Why do COX-2 inhibitors increase risk of cardiovascular events?
Frankish H
Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978344
[No Abstract] [Full Text] [Related]
14. Cardiovascular events and COX-2 inhibitors.
McGeer PL; McGeer EG; Yasojima K
JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735747
[No Abstract] [Full Text] [Related]
15. COX 2 inhibition and bowel strictures.
Maiden LP; Bjarnason I
Gut; 2004 Jul; 53(7):1057-8. PubMed ID: 15194667
[No Abstract] [Full Text] [Related]
16. [COX-2 specific inhibitors are similar--and different].
Aly A
Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
[No Abstract] [Full Text] [Related]
17. The coxibs, selective inhibitors of cyclooxygenase-2.
Nzerue CM
N Engl J Med; 2001 Dec; 345(23):1708-9. PubMed ID: 11759655
[No Abstract] [Full Text] [Related]
18. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study.
Mamdani M; Juurlink DN; Kopp A; Naglie G; Austin PC; Laupacis A
BMJ; 2004 Jun; 328(7453):1415-6. PubMed ID: 15138157
[No Abstract] [Full Text] [Related]
19. COX-2 inhibitors and Celebrex: safe or suspect?
Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
[No Abstract] [Full Text] [Related]
20. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
Palmer RH
JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
